美国国家综合癌症网络（NCCN）组织细胞增生症诊疗指南
发布于2021年3月
The ECDGA is pleased to announce that the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—has published a new NCCN Guidelines® for Histiocytosis. These clinical practice guidelines provide the latest evidence and expert-consensus for diagnosing and treating the three most common forms of histiocytosis in adults: Langerhans cell histiocytosis (LCH), Erdheim-Chester Disease (ECD,) and Rosai Dorfman Disease (RDD).
NCCN指南可帮助患者、家属和医生获取有关症状、诊断、治疗等方面的最新信息。在申请药物和疗法的保险报销审批时，这些指南也可作为有用的工具。点击此处获取您的指南副本： 免费注册 NCCN 账户, which many physicians actively use in their practices. The guidelines are updated at least once a year and can be accessed at any time. You can view the published guidelines on NCCN’s website within the following link, (listed as “histiocytic neoplasms”).
我们建议您将此信息告知您的医疗团队。.